HCID 16659853, compound → HCID 178517319, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[CH:4][C:5](O[C@H]2C[C@H](C(O)=O)C2)=[C:6]2[C:11]=1[NH:10][C:9](=[O:12])[NH:8][C:7]12[CH2:17][CH2:16][CH2:15][CH2:14][CH2:13]1.FC1C=CC(OCC2CC(C(O)=O)C2)=C2C=1NC(=O)NC12CCCCC1.C(C1C=CC([O:70][C@H:71]2[CH2:74][C@H:73]([C:75]([OH:77])=[O:76])[CH2:72]2)=C2C=1NC(=O)NC12CCCCC1)#N.FC1C=CC(OCC2(C(O)=O)CCC2)=C2C=1NC(=O)NC12CCCCC1>>[Cl:1][C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:11]=1[NH:10][C:9](=[O:12])[NH:8][C:7]12[CH2:17][CH:16]([O:70][C@@H:71]2[CH2:74][C@H:73]([C:75]([OH:77])=[O:76])[CH2:72]2)[CH2:15][CH2:14][CH2:13]1Participants
Procedure
trans-3-[(8′-Chloro-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclohexane-1,4′-quina-zolin]-5′-yl)oxy]cyclobutanecarboxylic acid; 3-[(8′-fluoro-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclohexane-1,4′-quinazolin]-5′-yl)oxymethyl]cyclobutanecarboxylic acid; trans-3-[(8′-cyano-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclohexane-1,4′-quinaz-olin]-5′-yl)oxy]cyclobutanecarboxylic acid; 1-[(8′-fluoro-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclohexane-1,4′-quinazolin]-5′-yl)oxymethyl]cyclobutanecarboxylic acid; trans-3-[(8′-chloro-2′-oxo-2′,3′-dihydro-1′H-spiro[cycloheptyl-1,4′-quina-zolin]-5′-yl)oxy]cyclobutanecarboxylic acid; and trans-3-[(8′-chloro-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclopentyl-1,4′-quinazolin]-5′-yl)oxy]cyclobutanecarboxylic acid; or a pharmaceutically acceptable salt, solvate, polymorph or prodrug thereof.
Sources & evidence
- ORD record
- ord-13afd7ace3cf4a28b0cee30de8814d8e
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09220715B2
Reaction notes
Loading…